|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Feb―12 |
The severe acute respiratory syndrome coronavirus 2 non-structural proteins 1 and 15 proteins mediate antiviral immune evasion |
Nitish Boodhoo, Ayumi Matsuyama, Bahram Shojadoost, Shahriar Behboudi, Shayan Sharif |
2 |
[GO] |
2022―Jan―15 |
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern |
Luca Murer, Romain Volle, Vardan Andriasyan, Anthony Petkidis, Alfonso Gomez-Gonzalez, Liliane Yang, et al. (+9) Nicole Meili, Maarit Suomalainen, Michael Bauer, Daniela Sequeira, Dominik Olszewski, Fanny Georgi, Fabien Kuttler, Gerardo Turcatti, Urs F. Greber |
3 |
[GO] |
2021―Nov―30 |
Association between the interferon-induced transmembrane protein 3 gene (IFITM3) rs34481144 / rs12252 haplotypes and COVID-19 |
Elías Cuesta-Llavona, Guillermo M. Albaiceta, Marta García-Clemente, Israel D. Duarte-Herrera, Laura Amado-Rodríguez, Tamara Hermida-Valverde, et al. (+9) Ana I. Enríquez-Rodriguez, Cristina Hernández-González, Santiago Melón, Marta E. Alvarez-Argüelles, José A. Boga, Susana Rojo-Alba, Daniel Vázquez-Coto, Juan Gómez, Eliecer Coto |
4 |
[GO] |
2021―Nov―18 |
Review Devil's tools: SARS-CoV-2 antagonists against innate immunity |
Duo Xu, Mahamaya Biswal, Arrmund Neal, Rong Hai |
5 |
[GO] |
2021―Nov―12 |
All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses |
Alessandra C. Setaro, Marta M. Gaglia |
6 |
[GO] |
2021―Aug―05 |
SARS-CoV-2 neutralising antibodies in dogs and cats in the United Kingdom |
Shirley L. Smith, Enyia R. Anderson, Cintia Cansado-Utrilla, Tessa Prince, Sean Farrell, Bethaney Brant, et al. (+8) Steven Smyth, Peter-John M. Noble, Gina L. Pinchbeck, Nikki Marshall, Larry Roberts, Grant L. Hughes, Alan D. Radford, Edward I. Patterson |
7 |
[GO] |
2021―Apr―05 |
SARS-CoV-2 NSP1 C-terminal (residues 131-180) is an intrinsically disordered region in isolation |
Amit Kumar, Ankur Kumar, Prateek Kumar, Neha Garg, Rajanish Giri |
|